• July 16, 2020

BIOCORP Signs Distribution Agreement for Mallya Technology With Roche Diabetes Care France - Odessa American: News

e-Edition Subscribe

BIOCORP Signs Distribution Agreement for Mallya Technology With Roche Diabetes Care France

Print
Font Size:
Default font size
Larger font size

Posted: Tuesday, June 30, 2020 12:30 am

ISSOIRE, France--(BUSINESS WIRE)--Jun 30, 2020--

Regulatory News:

BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, announces today the signature of a distribution contract for its Mallya connected device with Roche Diabetes Care France.

As part of the agreement, Roche Diabetes Care France will distribute Mallya to pharmacies in France. This medical device is an intelligent 2-year reusable injector pen sensor that is compatible with the majority of insulin injection pens, both disposable and reusable. It automatically collects the insulin dose delivered with near 100% accuracy.

In the future, Mallya will also be part of the RocheDiabetes ecosystem consisting of connected blood glucose meters (Accu-Chek Mobile, Accu-Chek Guide) and digital solutions for better patients care.

Gluci-Chek is a smartphone application regularly used by nearly 60,000 diabetic patients in France. It brings together three major functionalities for personalized diabetes management: a carbohydrate calculation tool with visualization of portions on the plate, a self-monitoring glycemic logbook and a graphic visualization of glycemic results.

Thanks to Mallya, the patient will no longer have to manually report the insulin doses injected in the future since, once the sensor is paired with the Gluci-Chek application, the data will be automatically reported and displayed in the blood glucose monitoring logbook, regardless of the insulin pen 1.

Frédéric Jacquey, President of Roche Diabetes Care France: “The signature of this agreement with Biocorp represents a fundamental step in the development of our ecosystem to improve the care of diabetic patients and their exchanges with healthcare professionals. With innovative technology like Mallya, we will soon be able to offer a unique offering for optimal patient care that integrates blood glucose data from our meters via Gluci-Chek and automatic insulin data via Mallya.”

Éric Dessertenne, CEO of BIOCORP: “Roche is the second pharmaceutical giant to integrate our Mallya connected device for optimal monitoring of diabetic patients into its commercial offer. I would like to thank the teams at Roche Diabetes Care France for their responsiveness over the last few weeks. This new structuring agreement confirms the ambitions presented to all our shareholders in early 2020 on the market of digitalization of diabetes and the considerable commercial potential of Mallya. With a partner of the calibre of Roche, we are confident that a large number of diabetics will quickly be able to benefit from the real benefits offered by Mallya on the secure monitoring of their daily insulin intake."

ABOUT DE ROCHE DIABETES CARE FRANCE

Roche Diabetes Care is a healthcare company specializing in diabetes. For more than 40 years, it has been designing solutions to meet the needs of both patients and healthcare professionals: medical devices (blood glucose meters, lancing devices, insulin pumps), services (information and therapeutic education support) and digital solutions (applications, platform for sharing blood glucose data between patients and healthcare professionals). By creating an ecosystem connecting medical devices and digital solutions, Roche Diabetes Care is paving the way for personalized diabetes management with the aim of facilitating and optimizing the management and monitoring of this complex disease.

Roche Diabetes Care France is a subsidiary of the Roche Group in France, alongside Roche SAS France and Roche Diagnostics France. For more information, please visit www.roche.fr.

ABOUT BIOCORP

Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 54 employees.

BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).

For more information, please visit www.biocorpsys.com.

Follow us on Twitter @BIOCORPSystems

1 SoloStar de Sanofi – KwikPen de Eli Lilly – FlexPen de Novo Nordisk

View source version on businesswire.com:https://www.businesswire.com/news/home/20200629005362/en/

CONTACT: BIOCORP CONTACTS

Sylvaine Dessard

rp@biocorp.fr

+ 33 (0)6 88 69 72 85Bruno ARABIAN

barabian@ulysse-communication.com

+33 (0)6 87 88 46 26ROCHE DIABETES CARE FRANCE CONTACTS

Myriam Hamza

rochediabpresse@havas.com

+33 (0)6 45 87 46 51Raphaële Badel

Raphaele.badel@roche.com

+33 (0)7 77 34 60 59

KEYWORD: FRANCE EUROPE

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES PRACTICE MANAGEMENT RESEARCH SCIENCE BIOTECHNOLOGY

SOURCE: BIOCORP

Copyright Business Wire 2020.

PUB: 06/30/2020 01:30 AM/DISC: 06/30/2020 01:30 AM

http://www.businesswire.com/news/home/20200629005362/en

© 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Sunny
79°
Humidity: 41%
Winds: ESE at 8mph
Feels Like: 80°

Your Extended Forecast

Tomorrow

weather
High 101°/Low 75°
Sunny. Highs 99 to 103F and lows in the mid 70s.

friday

weather
High 102°/Low 74°
Sunny. Highs 100 to 104F and lows in the mid 70s.

saturday

weather
High 99°/Low 72°
Sunny. Highs in the upper 90s and lows in the low 70s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.